Cargando…
In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines
BACKGROUND: Brain metastasis from breast cancer poses a major clinical challenge. Integrins play a role in regulating adhesion, growth, motility, and survival, and have been shown to be critical for metastatic growth in the brain in preclinical models. Cilengitide, an αvβ3/αvβ5 integrin inhibitor, h...
Autores principales: | Lautenschlaeger, Tim, Perry, James, Peereboom, David, Li, Bin, Ibrahim, Ahmed, Huebner, Alexander, Meng, Wei, White, Julia, Chakravarti, Arnab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816586/ https://www.ncbi.nlm.nih.gov/pubmed/24153102 http://dx.doi.org/10.1186/1748-717X-8-246 |
Ejemplares similares
-
Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012) -
In vitro and in vivo drug disposition of cilengitide in animals and human
por: Dolgos, Hugues, et al.
Publicado: (2016) -
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
por: Weller, Michael, et al.
Publicado: (2016) -
Gene expression profiling of the anti-glioma effect of Cilengitide
por: Onishi, Manabu, et al.
Publicado: (2013) -
SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells
por: Díaz Albuja, Johanna, et al.
Publicado: (2019)